Adenoviral Serotypes in Gene Therapy for Esophageal Carcinoma

Journal of Surgical Research

Volumn 140, Issue 1, 2007, Pages 50-54

  Marsman, Willem A ^a   Wesseling, John G ^a   el Bouch, Abelkarim ^a   Bosma, Piter J ^a   van Lanschot, J Jan B ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

adenovirus; Barrett's esophagus; esophageal cancer; gene therapy; serotypes

Indexed keywords

ADENOVIRUS VECTOR;

ADENOCARCINOMA; ARTICLE; BARRETT ESOPHAGUS; CANCER CELL CULTURE; CANCER GENE THERAPY; CELL DIFFERENTIATION; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FLOW CYTOMETRY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTESTINE METAPLASIA; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REPORTER GENE; SEROTYPING; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ADENOVIRIDAE; BARRETT ESOPHAGUS; CACO-2 CELLS; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL LINE, TUMOR; ESOPHAGEAL NEOPLASMS; GENE THERAPY; HUMANS; SEROTYPING; TRANSDUCTION, GENETIC;

EID: 34247571943     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2006.12.006     Document Type: Article

References (23)

1. Gomez-Navarro J., Curiel D.T., and Douglas J.T. Gene therapy for cancer. Eur J Cancer 35 (1999) 2039
2. Kanerva A., and Hemminki A. Modified adenoviruses for cancer gene therapy. Int J Cancer 110 (2004) 475
3. Rots M.G., Curiel D.T., Gerritsen W.R., et al. Targeted cancer gene therapy: The flexibility of adenoviral gene therapy vectors. J Control Release 87 (2003) 159
4. Wadell G. Molecular epidemiology of human adenoviruses. Curr Top Microbiol Immunol 110 (1984) 191
5. Bergelson J.M. Receptors mediating adenovirus attachment and internalization. Biochem Pharmacol 57 (1999) 975
6. Goossens P.H., Vogels R., Pieterman E., et al. The influence of synovial fluid on adenovirus-mediated gene transfer to the synovial tissue. Arthritis Rheum 44 (2001) 48
7. Yotnda P., Onishi H., Heslop H.E., et al. Efficient infection of primitive hematopoietic stem cells by modified adenovirus. Gene Ther 8 (2001) 930
8. Havenga M.J., Lemckert A.A., Ophorst O.J., et al. Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease. J Virol 76 (2002) 4612
9. Rea D., Havenga M.J., van Den A.M., et al. Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells. J Immunol 166 (2001) 5236
10. Havenga M.J., Lemckert A.A., Grimbergen J.M., et al. Improved adenovirus vectors for infection of cardiovascular tissues. J Virol 75 (2001) 3335
11. Hehir K.M., Armentano D., Cardoza L.M., et al. Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence. J Virol 70 (1996) 8459
12. Shabram P.W., Giroux D.D., Goudreau A.M., et al. Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles. Hum Gene Ther 8 (1997) 453
13. Nishihira T., Kasai M., Mori S., et al. Characteristics of two cell lines (TE-1 and TE-2) derived from human squamous cell carcinoma of the esophagus. Gann 70 (1979) 575
14. Rockett J.C., Larkin K., Darnton S.J., et al. Five newly established esophageal carcinoma cell lines: Phenotypic and immunological characterization. Br J Cancer 75 (1997) 258
15. Wesseling J.G., Bosma P.J., Krasnykh V., et al. Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors. Gene Ther 8 (2001) 969
16. Hierholzer J.C. Further subgrouping of the human adenoviruses by differential hemagglutination. J Infect Dis 128 (1973) 541
17. Wadell G. Classification of human adenoviruses by SDS-polyacrylamide gel electrophoresis of structural polypeptides. Intervirology 11 (1979) 47
18. Bailey A., and Mautner V. Phylogenetic relationships among adenovirus serotypes. Virology 205 (1994) 438
19. Uhnoo I., Wadell G., Svensson L., et al. Importance of enteric adenoviruses 40 and 41 in acute gastroenteritis in infants and young children. J Clin Microbiol 20 (1984) 365
20. De Jong J.C., Wermenbol A.G., Verweij-Uijterwaal M.W., et al. Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively. J Clin Microbiol 37 (1999) 3940
21. Rice T.W., Falk G.W., Achkar E., et al. Surgical management of high-grade dysplasia in Barrett's esophagus. Am J Gastroenterol 88 (1993) 1832
22. Gaggar A., Shayakhmetov D.M., and Lieber A. CD46 is a cellular receptor for group B adenoviruses. Nat Med 9 (2003) 1408
23. Ni S., Gaggar A., Di Paolo N., et al. Evaluation of adenovirus vectors containing serotype 35 fibers for tumor targeting. Cancer Gene Ther (2006)